IMS 2022 | Factors to consider for the optimal management of relapse in multiple myeloma
Yael Cohen
• 27 Jul 2022
Yael Cohen, MD, Tel-Aviv Sourasky Medical center, Tel-Aviv, Israel, outlines some of the factors that need to be considered by clinicians when managing patients with multiple myeloma who experience relapse, including type and timing of relapse, treatment toxicity, and presence of comorbidities. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
